1993 – 2007
Here is a list of older publications from members of the Dittmer lab.
1993
Gain of function mutations in p53.
Dittmer D, Pati S, Zambetti G, Chu S, Teresky AK, Moore M, Finlay C, Levine AJ.
Nat Genet. 1993 May;4(1):42-6.
PMID:
1997
Human cytomegalovirus infection inhibits G1/S transition.
Dittmer D, Mocarski ES.
J Virol. 1997 Feb;71(2):1629-34.
PMID:
1999
Experimental transmission of Kaposi’s sarcoma-associated herpesvirus (KSHV/HHV-8) to SCID-hu Thy/Liv mice.
Dittmer D, Stoddart C, Renne R, Linquist-Stepps V, Moreno ME, Bare C, McCune JM, Ganem D.
J Exp Med. 1999 Dec 20;190(12):1857-68.
PMID:
2003
Transcription profile of Kaposi’s sarcoma-associated herpesvirus in primary Kaposi’s sarcoma lesions as determined by real-time PCR arrays.
Dittmer DP.
Cancer Res. 2003 May 1;63(9):2010-5.
PMID:
Viral latent proteins as targets for Kaposi’s sarcoma and Kaposi’s sarcoma-associated herpesvirus (KSHV/HHV-8) induced lymphoma.
Staudt MR, Dittmer DP.
Curr Drug Targets Infect Disord. 2003 Jun;3(2):129-35. Review.
PMID:
2004
The tumor microenvironment controls primary effusion lymphoma growth in vivo.
Staudt MR, Kanan Y, Jeong JH, Papin JF, Hines-Boykin R, Dittmer DP.
Cancer Res. 2004 Jul 15;64(14):4790-9.
PMID:
A baboon model for herpesvirus infection and pathogenesis.
Papin JF, Wolf R, Dittmer DP.
Recent Res. Devel. Virol., 6 (2004)
2005
Kaposi’s sarcoma in the era of HAART-an update on mechanisms, diagnostics and treatment.
Dittmer DP, Vahrson W, Staudt M, Hilscher C, Fakhari FD.
AIDS Rev. 2005 Jan-Mar;7(1):56-61. Review.
PMID:
De novo generation of CD4 T cells against viruses present in the host during immune reconstitution.
Kalina T, Lu H, Zhao Z, Blewett E, Dittmer DP, Randolph-Habecker J, Maloney DG, Andrews RG, Kiem HP, Storek J.
Blood. 2005 Mar 15;105(6):2410-4. Epub 2004 Oct 12.
PMID:
Whole-genome transcription profiling of rhesus monkey rhadinovirus.
Dittmer DP, Gonzalez CM, Vahrson W, DeWire SM, Hines-Boykin R, Damania B.
J Virol. 2005 Jul;79(13):8637-50.
PMID:
Azidothymidine inhibits NF-kappaB and induces Epstein-Barr virus gene expression in Burkitt lymphoma.
Kurokawa M, Ghosh SK, Ramos JC, Mian AM, Toomey NL, Cabral L, Whitby D, Barber GN, Dittmer DP, Harrington WJ Jr.
Blood. 2005 Jul 1;106(1):235-40. Epub 2005 Mar 24.
PMID:
Role of Notch signal transduction in Kaposi’s sarcoma-associated herpesvirus gene expression.
Chang H, Dittmer DP, Shin YC, Hong Y, Jung JU.
J Virol. 2005 Nov;79(22):14371-82. Erratum in: J Virol. 2006 Apr;80(8):4203. Chul, Shin-Young [corrected to Shin, Young C].
PMID:
Faster quantitative real-time PCR protocols may lose sensitivity and show increased variability.
Hilscher C, Vahrson W, Dittmer DP.
Nucleic Acids Res. 2005 Nov 27;33(21):e182.
PMID:
Methylene blue photoinactivation abolishes West Nile virus infectivity in vivo.
Papin JF, Floyd RA, Dittmer DP.
Antiviral Res. 2005 Nov;68(2):84-7. Epub 2005 Aug 9.
PMID:
Real-time quantitative PCR analysis of viral transcription.
Papin J, Vahrson W, Hines-Boykin R, Dittmer DP.
Methods Mol Biol. 2005;292:449-80.
PMID:
2006
The latency-associated nuclear antigen of Kaposi sarcoma-associated herpesvirus induces B cell hyperplasia and lymphoma.
Fakhari FD, Jeong JH, Kanan Y, Dittmer DP.
J Clin Invest. 2006 Mar;116(3):735-42. Epub 2006 Feb 23.
PMID:
Tumorigenesis: A step towards viral transformation.
Bangham J.
Nat Rev Cancer. 2006 Apr;6:254-55.
Immortalization of primary endothelial cells by the K1 protein of Kaposi’s sarcoma-associated herpesvirus.
Wang L, Dittmer DP, Tomlinson CC, Fakhari FD, Damania B.
Cancer Res. 2006 Apr 1;66(7):3658-66.
PMID:
Baboon model for West Nile virus infection and vaccine evaluation.
Wolf RF, Papin JF, Hines-Boykin R, Chavez-Suarez M, White GL, Sakalian M, Dittmer DP.
Virology. 2006 Nov 10;355(1):44-51. Epub 2006 Aug 10.
PMID:
2007
Reactivation of Kaposi’s sarcoma-associated herpesvirus by natural products from Kaposi’s sarcoma endemic regions.
Whitby D, Marshall VA, Bagni RK, Miley WJ, McCloud TG, Hines-Boykin R, Goedert JJ, Conde BA, Nagashima K, Mikovits J, Dittmer DP, Newman DJ.
Int J Cancer. 2007 Jan 15;120(2):321-8.
PMID:
Functional p53 signaling in Kaposi’s sarcoma-associated herpesvirus lymphomas: implications for therapy.
Petre CE, Sin SH, Dittmer DP.
J Virol. 2007 Feb;81(4):1912-22. Epub 2006 Nov 22.
PMID:
In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi’s sarcoma.
Mutlu AD, Cavallin LE, Vincent L, Chiozzini C, Eroles P, Duran EM, Asgari Z, Hooper AT, La Perle KM, Hilsher C, Gao SJ, Dittmer DP, Rafii S, Mesri EA.
Cancer Cell. 2007 Mar;11(3):245-58. Erratum in: Cancer Cell. 2007 May;11(5):471.
PMID:
Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling.
Sin SH, Roy D, Wang L, Staudt MR, Fakhari FD, Patel DD, Henry D, Harrington WJ Jr, Damania BA, Dittmer DP.
Blood. 2007 Mar 1;109(5):2165-73. Epub 2006 Nov 2.
PMID:
Development of a fluorescence-based assay to screen antiviral drugs against Kaposi’s sarcoma associated herpesvirus.
Nun TK, Kroll DJ, Oberlies NH, Soejarto DD, Case RJ, Piskaut P, Matainaho T, Hilscher C, Wang L, Dittmer DP, Gao SJ, Damania B.
Mol Cancer Ther. 2007 Aug;6(8):2360-70.
PMID:
Targeted therapy for Kaposi’s sarcoma and Kaposi’s sarcoma-associated herpesvirus.
Dittmer DP, Krown SE.
Curr Opin Oncol. 2007 Sep;19(5):452-7. Review.
PMID:
AIDS related malignancies in Brazil.
Sampaio J, Brites C, Araujo I, Bacchi CE, Dittmer DP, Tanaka PY, Harrington W Jr, Netto EM.
Curr Opin Oncol. 2007 Sep;19(5):476-8. Review.
PMID:
The Rta/Orf50 transactivator proteins of the gamma-herpesviridae.
Staudt MR, Dittmer DP.
Curr Top Microbiol Immunol. 2007;312:71-100. Review.
PMID:
KSHV-associated disease in the AIDS patient.
Dittmer DP, Damania B.
Cancer Treat Res. 2007;133:129-39. Review. No abstract available.
PMID:
Liposomal daunorubicin as treatment for Kaposi’s sarcoma.
Petre CE, Dittmer DP.
Int J Nanomedicine. 2007;2(3):277-88. Review.
PMID:18019828